Prasco Laboratories
Generated 5/10/2026
Executive Summary
Prasco Laboratories is a leading pharmaceutical commercialization partner specializing in Authorized Generics, founded in 1995 and based in Cincinnati, Ohio. The company partners with over 60 major brand-name pharmaceutical companies to bring identical, brand-quality products to market under a generic label, thereby providing affordable medication access to patients. Operating on Christian principles, Prasco's mission is to create value for its partners, deliver service to customers, and improve patient access to cost-effective medicines. As a private company, Prasco has a proven track record in the authorized generic space, leveraging deep industry relationships and operational expertise. The company does not disclose financials or pipeline details, but its business model is generally stable and recurring, given long-term partnerships with brand manufacturers. With the growing trend of healthcare cost containment and increased utilization of generics, Prasco is well-positioned to continue serving as a bridge between brand innovation and generic accessibility.
Upcoming Catalysts (preview)
- Q2 2026New Partnership with a Major Brand Pharmaceutical Company70% success
- Q4 2026Expansion into High-Value Therapeutic Categories (e.g., Biologics Authorized Generics)50% success
- Q3 2026Regulatory Milestone: FDA Approval for a Key Authorized Generic Product60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)